Retinal Vein Occlusion Market Statistics by Types, Condition, Diagnosis and Forecast to 2023

The Global Retinal Vein Occlusion Market is expected to grow at a CAGR of 11.2% during the forecast period 2017-2023.

Major Market Players:

Some of the largest players in this market are IRIDEX Corporation, ZEISS, Allergan, Astrazeneca, Valeant Pharmaceuticals, Bayer, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Ellex Medical Lasers, Novartis, Quantel Medical Inc, Johnson & Johnson Services, Inc, Topcon Medical Systems, Inc., Lumenis, GlaxoSmithKline Plc, Annexin Pharmaceuticals AB  Sanofi Aventis, Alimera Sciences, Icon Biosciences, Suzuken Co.Ltd, Genentech, Inc.,  Fovea Pharmaceuticals SA, Ranbaxy Pharmaceuticals, Teva Pharmaceutical, Pfizer Inc., Aerpio Therapeutics Inc, and others.

Market Overview:

Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. However, it is the second most common cause of vision loss from retinal vascular disease after diabetic retinopathy. The market for retinal vein occlusion is expected to grow at an exponential rate owing to an increasing prevalence of eye diseases and chronic diseases such as diabetes, which are major risk factors for eye disease. Furthermore, rising demand for better treatment methods for eye diseases is fueling the market growth. Consequently, the majority of the market players have a great opportunity in this market as they use strategic approaches such as geographical expansion.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/5377 .

The retinal vein occlusion market is changing continuously during the last few decades and is expecting a huge development in coming future. Through extensive research, it is found that the market players have adopted the strategy of FDA approvals and acquisitions to expand their market. The key players involved in this strategy are Allergan, Bayer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Ellex Medical Lasers, GlaxoSmithKline Plc, IRIDEX Corporation. FDA approvals (25%) was the most widely adopted strategy which was adopted by the key market players. The number of key market players involved in distribution agreement (30%), collaboration (15%) and clinical trials (10%), and others were comparatively low. The market players which were involved in others are Novartis, Quantel Medical Inc, Topcon Medical Systems, Inc., and ZEISS among others in the global retinal vein occlusion market.

However, high cost and side-effects associated with the treatment may affect the growth of the global retinal vein occlusion market negatively.

Regional Analysis

The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.

Europe holds the second position in the market owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current health care expenditure of EUR 237 billion.

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/5377 .

The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare sector and developing medical facilities, which will boost the market of this region.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

LIST OF TABLES

Table 1 Primary Interviews

Table 2 Global Retinal Vein Occlusion Market for Branch Retinal Artery Occlusion
By Region, 2014-2023 (USD Million)

Table 3 Global Retinal Vein Occlusion Market for Central Retinal Vein Occlusion,
By Region, 2014-2023 (USD Million)

Table 4 Global Retinal Vein Occlusion Market for Non-Ischemic, By Region, 2014-2023 (USD Million)

Table 5 Global Retinal Vein Occlusion Market For Ischemic, By Region, 2014-2023 (USD Million)

Table 6 Global Retinal Vein Occlusion Market for Optical Coherence Tomography,
By Region, 2014-2023 (USD Million)

LIST OF FIGURES

Figure 1 Global Retinal Vein Occlusion Market, By Type, 2016 (%)

Figure 2 Global Retinal Vein Occlusion Market, By Condition, 2016 (%)

Figure 3 Global Retinal Vein Occlusion Market, By Diagnosis, 2016 (%)

Figure 4 Global Retinal Vein Occlusion Market, By Treatment, 2016 (%)

Figure 5 Global Retinal Vein Occlusion Market, By End User, 2016 (%)

Figure 6 Global Retinal Vein Occlusion Market, By Region, 2016 (%)

…Continued

Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/5377 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com